FAM
NNVC icon

Flaharty Asset Management’s NanoViricides NNVC Stock Holding History

Flaharty Asset Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-400
Closed -$600 – 313
2024
Q3 		$600 Buy
+400
New +$743 ﹤0.01% 432
2023
Q4 		– Sell
-200
Closed -$268 – 326
2023
Q3 		$268 Buy
+200
New +$283 ﹤0.01% 462

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Flaharty Asset Management's NNVC Position: Q4 2024 in Review

Flaharty Asset Management sold out of NanoViricides (NNVC) in Q4 2024, closing a stake of 400 shares — an estimated $600 sold.

Flaharty Asset Management first reported a position in NNVC in Q3 2023 and held it in 2 quarters. The position peaked at $600 in Q3 2024. 36 funds tracked by Wall St. Rank hold NNVC as of Q4 2024.

  • Flaharty Asset Management reported no remaining NanoViricides position as of Q4 2024 after selling out during the quarter.
  • Flaharty Asset Management sold 400 NanoViricides shares in Q4 2024, an estimated $600.
  • Flaharty Asset Management first reported a position in NanoViricides in Q3 2023 and held it in 2 quarters.
  • Flaharty Asset Management's NanoViricides position peaked at $600 in Q3 2024.
  • 36 funds tracked by Wall St. Rank held NanoViricides as of Q4 2024.

Based on Flaharty Asset Management's 13F filing for Q4 2024, filed 5 Feb 2025.